Cargando…

Characteristics of Pharmacists' Interventions Related to Proton-Pump Inhibitors in French Hospitals: An Observational Study

METHODS: The study was based on a retrospective analysis of pharmacist interventions for DRPs detected during the medication order review and documented into the French Act-IP© database over a 12-year period. DRPs and PIs were analyzed, and independent factors of physician acceptance were assessed v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yailian, AL, Huet, E., Charpiat, B., Conort, O., Juste, M., Roubille, R., Bourdelin, M., Gravoulet, J., Mongaret, C., Vermorel, C., Bedouch, P., Janoly-Duménil, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256420/ https://www.ncbi.nlm.nih.gov/pubmed/35846437 http://dx.doi.org/10.1155/2022/9619699

Ejemplares similares

Characteristics of pharmacist’s interventions triggered by prescribing errors related to computerised physician order entry in French hospitals: a cross-sectional observational study
por: Videau, Manon, et al.
Publicado: (2021)

Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
por: Charpiat, Bruno, et al.
Publicado: (2020)

Practices among General Practitioners in Rheumatoid Arthritis (GEPRA-I): results of a region-wide online survey
por: Yailian, Anne-Laure, et al.
Publicado: (2022)

Community pharmacists’ views on their current role and future opportunities for antibiotic stewardship: a French qualitative study
por: Essilini, Anaïs, et al.
Publicado: (2021)

Predictive factors for clinically significant pharmacist interventions at hospital admission
por: Mongaret, Céline, et al.
Publicado: (2018)

Evidence-Based Pharmaceutical Care in Community Pharmacies: A Survey of 595 French Pharmacists
por: Bosson, Louis, et al.
Publicado: (2023)

Démarche qualité à l’officine en période de crise sanitaire : enquête auprès de pharmaciens en Auvergne Rhône-Alpes
por: Vallet, M.-A., et al.
Publicado: (2022)

The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
por: Boardman, Helen F., et al.
Publicado: (2015)

Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors
por: Alhossan, Abdulaziz, et al.
Publicado: (2019)

Promouvoir la vaccination au sein des populations à risque : l’équipe pharmaceutique hospitalière s’implique !
por: Laloi, L., et al.
Publicado: (2022)

Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
por: Armstrong, David, et al.
Publicado: (2016)

Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
por: Bhardwaj, Sonia, et al.
Publicado: (2022)

Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study
por: Zecchini, Céline, et al.
Publicado: (2020)

Impact of Clinical Pharmacists’ Recommendations on a Proton Pump Inhibitor Taper Protocol in an Ambulatory Care Practice
por: Bundeff, Andrew W., et al.
Publicado: (2013)

Clinical and Organizational Impacts of Medical Ordering Settings on Patient Pathway and Community Pharmacy Dispensing Process: The Prospective ORDHOSPIVILLE Study
por: Clarenne, Justine, et al.
Publicado: (2021)

Medication adherence in pediatric transplantation and assessment methods: a systematic review
por: Hoegy, Delphine, et al.
Publicado: (2019)

(De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database
por: Gendre, Pauline, et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Impact of Pharmacists-Led Interventions in Primary Care for Adults with Type 2 Diabetes on HbA1c Levels: A Systematic Review and Meta-Analysis
por: Coutureau, Claire, et al.
Publicado: (2022)

Insulin Pump Therapy Training and Management: An Opportunity for Community Pharmacists
por: Boyd, LeAnn C., et al.
Publicado: (2008)

Who has the guts to deprescribe proton pump inhibitors? A pharmacist‐led intervention in a long‐term care facility setting
por: Tandun, Rachel, et al.
Publicado: (2019)

Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies
por: Srinutta, Thawin, et al.
Publicado: (2019)

Use of proton pump inhibitors in scandinavian children and adolescents: An observational study
por: Closs, Emilie Raaum, et al.
Publicado: (2023)

Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists’ effect on prescribing practice at a tertiary hospital
por: Luo, Hongli, et al.
Publicado: (2018)

Clinical evaluation of pharmacists’ interventions on multidisciplinary lung transplant outpatients’ management: results of a 7-year observational study
por: Duwez, Marion, et al.
Publicado: (2020)

Predictors for inappropriate proton pump inhibitor use: observational study in primary care
por: Koggel, Lieke Maria, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Progress with proton pump inhibition.
por: Bell, N. J., et al.
Publicado: (1992)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Pharmacist and Physician Satisfaction and Rates of Switching to Preferred Medications Associated with an Instant Prior Authorization Program for Proton Pump Inhibitors in the North Carolina Medicaid Program
por: Jacobson Vann, Julie C., et al.
Publicado: (2010)

Intra‐aortic balloon pump: is the technique really outdated?
por: Akodad, Mariama, et al.
Publicado: (2020)

Pediatric-Adult Care Transition: Perceptions of Adolescent and Young Adult Patients with Sickle Cell Disease and Their Healthcare Providers
por: Hoegy, Delphine, et al.
Publicado: (2022)

The Role of Community Pharmacists in the Detection of Clinically Relevant Drug-Related Problems in Chronic Kidney Disease Patients
por: Mongaret, Céline, et al.
Publicado: (2020)

Proton pump inhibitors as a risk factor for norovirus infection
por: PRAG, C., et al.
Publicado: (2017)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies
por: Wu, Chieh-Chen, et al.
Publicado: (2023)

Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies
por: Yang, Yi, et al.
Publicado: (2017)

Acceleration Of Polarized Protons In Saturne. (in French)
por: Faure, J, et al.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_uce8fv1f5311gfbm2rlavkulp5